Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GRAZOPREVIR for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 123 adverse event reports in the FDA FAERS database where GRAZOPREVIR was used for Chronic hepatitis c.

Most Reported Side Effects for GRAZOPREVIR

Side Effect Reports % Deaths Hosp.
Hepatic function abnormal 29 11.8% 0 14
Renal impairment 17 6.9% 0 4
Liver disorder 15 6.1% 1 5
Nausea 12 4.9% 1 3
Pneumonia 12 4.9% 3 6
Anaemia 10 4.1% 3 1
Diarrhoea 10 4.1% 2 2
Alanine aminotransferase increased 9 3.7% 0 2
Drug-induced liver injury 9 3.7% 0 4
Headache 9 3.7% 1 0
Vomiting 9 3.7% 1 4
Decreased appetite 8 3.3% 0 2
Fatigue 8 3.3% 1 0
Cardiac failure 7 2.9% 2 1
Hepatic failure 7 2.9% 2 1

Other Indications for GRAZOPREVIR

Hepatitis c (59) Hepatic cirrhosis (16) Viraemia (7)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

GRAZOPREVIR Full Profile All Chronic hepatitis c Drugs GRAZOPREVIR Demographics GRAZOPREVIR Timeline